Enter your ZIP code:

Please enter a 5 digit zipcode
No results...

Entering your zip code helps us to provide information and results that are more relevant to you.

Your privacy is important to us. By continuing, you agree to our Privacy Policy.





Hand with white-coat sleeve holds a medication bottle while using a computer mouse

340B Program

About UCI Health

UCI Health serves a substantial population comprising nearly 5.6 million individuals in Orange County, western Riverside County and southeast Los Angeles County. As the sole academic health system in Orange County, UCI Health is committed to advancing medical knowledge, educating future healthcare professionals, and delivering the highest-quality, evidence-based healthcare. The 1,461-bed system comprises its main campus UCI Health — Orange, its flagship hospital, the UCI Health — Irvine acute care hospital and medical campus, four hospitals and affiliated physicians of the UCI Health Community Network in Orange and Los Angeles counties and a network of ambulatory care centers across the region. UCI Health — Orange provides tertiary and quaternary care and is the sole Orange-based National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. UCI Health is also notable for having federally qualified health centers in Anaheim and Santa Ana.

The 340B prescription drug program supports our role as a safety-net provider in offering vital healthcare services for the communities we serve. Program eligibility is based on substantial services to low-income Medicare and Medicaid patients. 340B hospitals – which include trauma centers, labor and delivery services, HIV-AIDS services and immunizations – provide significantly more money-losing but vital health services than non-340B hospitals. 

Given the absence of a county hospital, roughly 75% of the UCI Health patient base relies on government payers for insurance coverage. Notably, California possesses one of the nation's lowest Medicaid provider reimbursement rates, and the costs associated with specialty services often exceed the reimbursement received. Consequently, UCI Health bears the burden of uncompensated costs related to services in areas such as cancer care, trauma care, burn care, mental health services, organ transplant procedures and emergency care.

340B by the numbers (fiscal year 2025)

  • $195.66 million – Approximate annual 340B savings that benefit UCI Health patients
  • $1.08 billion – Total cost of uncompensated care provided, including charity care, Medicaid underpayment, bad debt and $625 million provided to Medicare beneficiaries
  • 36% – UCI Health's Disproportionate Share Hospital (DSH) percentage

Direct and indirect benefits of the 340B Program

brain and cog icon

Innovative care and technology

Colonoscopies that employ artificial intelligence for more accurate cancer testing

hospital icon

Specialized and essential clinical services

Otherwise financially nonviable services, including kidney and pancreas transplants

Behavioral health services

Level I (adult) and Level II (pediatric) trauma services

Burn and emergency services

meditation icon

Prevention, wellness and chronic disease support

Perinatal, cancer, obesity and chronic disease support groups

Preventive care and mental health services, including meditation programs

info icon

Education, research and community engagement

Lectures by internationally renowned subject-matter experts on groundbreaking research and disease/treatment outcomes.

fruit bowl icon

Food security and social support

Access to fresh produce through the UC Irvine Family Health Center food pantry

Potential impact of scaling back the 340B Program

UCI Health operates as a self-sustaining institution and does not receive any operational funding from the state of California or the University of California system. Its primary sources of support are federally funded Medicaid DSH (Disproportionate Share Hospital) dollars and discounts obtained from drug manufacturers through the 340B program. These critical funds enable UCI Health to provide essential medical care to low-income and underserved patients facing severe medical conditions, regardless of their financial means.

The advantages derived from the 340B program empower UCI Health to offer clinical services that would otherwise be financially unfeasible, particularly to vulnerable patient populations. By realizing savings through the 340B program, UCI Health can extend access to medical facilities that deliver life-saving treatments for conditions such as cancer, HIV (Human Immunodeficiency Virus), hepatitis C, asthma, and kidney failure to Medicaid recipients and uninsured individuals. The absence of these funds would compel UCI Health to reduce the scope of its emergency medicine, trauma care, mental health services, and cancer treatments.